Document:

EX-10.9

 Exhibit 10.9 
  

 
 December [    ], 2015 

[Employee Name] 
 BioMed Realty Trust, Inc. 

17190 Bernardo Center Drive 
 San Diego, California 92128 

RE:   Section 280G Treatment 

BioMed Realty Trust, Inc. and BioMed Realty, L.P. (together, the “Company”) and [Employee Name] (the
“Employee”) hereby agree to the following: 
 1. Section 280G Treatment.  

In the event that any payment or benefit received or to be received by the Employee pursuant to the terms of any plan, arrangement or agreement
(including any payment or benefit received in connection with a change of control or the termination of the Employee’s employment) (all such payments and benefits being hereinafter referred to as the “Total Payments”) would be
subject (in whole or part) to the excise tax (the “Excise Tax”) imposed under Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”), then the Total Payments shall be reduced to the extent
necessary so that no portion of the Total Payments is subject to the Excise Tax but only if (i) the net amount of such Total Payments, as so reduced (after subtracting the amount of federal, state and local income taxes on such reduced Total
Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced Total Payments) is greater than or equal to (ii) the net amount of such Total Payments without such reduction
(after subtracting the net amount of federal, state and local income taxes on such Total Payments and the amount of Excise Tax to which the Employee would be subject in respect of such unreduced Total Payments and after taking into account the phase
out of itemized deductions and personal exemptions attributable to such unreduced Total Payments). The Total Payments shall be reduced in the following order: (A) reduction of any cash severance payments otherwise payable to the Employee that
are exempt from Section 409A of the Code, (B) reduction of any other cash payments or benefits otherwise payable to the Employee that are exempt from Section 409A of the Code, but excluding any payment attributable to the acceleration
of vesting or payment with respect to any equity award with respect to the Company’s common stock that is exempt from Section 409A of the Code, (C) reduction of any other payments or benefits otherwise payable to the Employee on a
pro-rata basis or such other manner that complies with Section 409A of the Code, but excluding any payment attributable to the acceleration of vesting and payment with respect to any equity award with respect to the Company’s common stock
that is exempt from Section 409A of the Code, and (D) reduction of any payments attributable to the acceleration of vesting or payment with respect to any equity award with respect to the Company’s common stock that is exempt from
Section 409A of the Code. The foregoing reductions shall be made in a manner that results in the maximum economic benefit to the Employee and, to the extent economically equivalent, in a pro rata manner. 

For purposes of determining whether and the extent to which the Total Payments will be subject to the Excise Tax, (i) no portion of the
Total Payments the receipt or enjoyment of which the Employee shall have waived at such time and in such manner as not to constitute a “payment” within the meaning of Section 280G(b) of the Code shall be taken into account,
(ii) no portion of the Total Payments shall be taken into account which, in the written opinion of an accounting firm or compensation consulting firm with nationally recognized standing and substantial expertise and experience on
Section 280G matters (the “280G Firm”) selected by the Company, does not constitute a “parachute payment” within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of
the Code) and, in calculating the Excise Tax, no portion of such Total Payments shall be taken into account which, in the opinion of the 280G Firm, constitutes reasonable 

  

					
	t 858 485 9840  f  858 485 9843	  	17190 Bernardo Center Drive, San Diego, CA 92128	  	biomedrealty.com

 
compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the Base Amount (as defined in Section 280G(b)(3) of the Code)
allocable to such reasonable compensation, and (iii) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the 280G Firm in accordance with the principles of Sections
280G(d)(3) and (4) of the Code. All determinations related to the calculations to be performed pursuant to this Section 1 shall be done by the 280G Firm. 

The 280G Firm will be directed to submit its determination and detailed supporting calculations to both the Employee and the Company within
fifteen (15) days after notification from either the Company or the Employee that the Employee may receive payments which may be “parachute payments.” The Employee and the Company will each provide the 280G Firm access to and copies
of any books, records, and documents in their possession as may be reasonably requested by the 280G Firm, and otherwise cooperate with the 280G Firm in connection with the preparation and issuance of the determinations and calculations contemplated
by this letter agreement. The fees and expenses of the 280G Firm for its services in connection with the determinations and calculations contemplated by this letter agreement will be borne by the Company. 

2. Arbitration. Any disagreement, dispute, controversy or claim arising out of or relating to this letter agreement or the
interpretation of this letter agreement or any arrangements relating to this letter agreement or contemplated in this letter agreement or the breach, termination or invalidity thereof shall be settled by final and binding arbitration administered by
JAMS/Endispute in San Diego, California in accordance with the then existing JAMS/Endispute Arbitration Rules and Procedures for Employment Disputes. In the event of such an arbitration proceeding, the Employee and the Company shall select a
mutually acceptable neutral arbitrator from among the JAMS/Endispute panel of arbitrators. In the event the Employee and the Company cannot agree on an arbitrator, the Administrator of JAMS/Endispute will appoint an arbitrator. Neither the Employee
nor the Company nor the arbitrator shall disclose the existence, content, or results of any arbitration hereunder without the prior written consent of all parties. Except as provided herein, the Federal Arbitration Act shall govern the
interpretation, enforcement and all proceedings. The arbitrator shall apply the substantive law (and the law of remedies, if applicable) of the state of California, or federal law, or both, as applicable, and the arbitrator is without jurisdiction
to apply any different substantive law. The arbitrator shall have the authority to entertain a motion to dismiss and/or a motion for summary judgment by any party and shall apply the standards governing such motions under the Federal Rules of Civil
Procedure. The arbitrator shall render an award and a written, reasoned opinion in support thereof. Judgment upon the award may be entered in any court having jurisdiction thereof. The Company will pay the direct costs and expenses of the
arbitration. The Employee and the Company shall be responsible for their respective attorneys’ fees incurred in connection with enforcing this letter agreement. 

3. No Representation. This letter agreement and the actions taken pursuant thereto do not constitute a representation by the
Company that the Employee will not be subject to the Excise Tax and no action taken pursuant to this letter agreement or failure to act shall subject the Company or any of its subsidiaries or affiliates to any claim, liability or expense relating
to, and the Company shall not have any obligation to indemnify or otherwise protect the Executive from the obligation to pay, any taxes, interest or penalties pursuant to Section 4999 of the Code. 

4. Entire Agreement. This letter agreement constitutes the final, complete and exclusive agreement between the Employee and the
Company with respect to the subject matter hereof and replaces and supersedes any and all other agreements, offers or promises, whether oral or written, made to the Employee by the Company[, including, without limitation, Section 6 of that
Change in Control and Severance Agreement, dated as of [            ], by and between the Company and the Employee]. 

5. Governing Law. This letter agreement shall be governed by and construed in accordance with the laws of the State of
California, without reference to principles of conflict of laws. The captions of this letter agreement are not part of the provisions hereof and shall have no force or effect. This letter agreement may not be amended or modified other than by a
written agreement executed by the parties hereto or their respective successors and legal representatives. 

  
 Page 2 

 6. Notices. All notices and other communications hereunder shall be in writing and
shall be given by hand delivery to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 

If to the Employee: at the Employee’s most recent address on the records of the Company. 

If to the Company: 

BioMed Realty Trust, Inc. 

BioMed Realty, L.P. 

17190 Bernardo Center Drive 

San Diego, California 92128 

Attn: General Counsel 
 or to
such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee. 

7. Severability. The invalidity or unenforceability of any provision of this letter agreement shall not affect the validity or
enforceability of any other provision of this letter agreement. 
 8. Survival. Provisions of this letter agreement shall
survive any termination of this letter agreement if so provided herein or if necessary or desirable to fully accomplish the purposes of such provision. 

9. Counterparts. This letter agreement may be executed simultaneously in two counterparts, each of which shall be deemed an
original but which together shall constitute one and the same instrument. 

  
 Page 3 

 
			
	Accepted, Acknowledged and Agreed:
	
	BIOMED REALTY TRUST, INC.
		
	By:	 	  

	Name:	 	Jonathan P. Klassen
	Title:	 	EVP, General Counsel and Secretary
		 	
		 	
	  

	[Employee Name]

  
 Page 4EX-10.10

 Exhibit 10.10 

BIOMED REALTY TRUST, INC. 

AND 
 BIOMED REALTY, L.P.

 LTIP UNIT AWARD CANCELLATION AGREEMENT 

This LTIP Unit Award Cancellation Agreement (this “Agreement”), is executed and made effective as of
December 30, 2015, by and between BioMed Realty Trust, Inc., a Maryland corporation (the “Corporation”), BioMed Realty, L.P., a Maryland limited partnership (the “Partnership,” and, together with
the Corporation, the “Company”), and Gary A. Kreitzer (the “Executive”). 
 WHEREAS, the
Corporation has entered into that certain Agreement and Plan of Merger, dated as of October 7, 2015, among the Corporation, the Partnership, BRE Edison Holdings, L.P. (“Parent”), BRE Edison L.P. and BRE Edison
Acquisition L.P. (the “Merger Agreement”), pursuant to which the Corporation will become a wholly-owned subsidiary of Parent; 

WHEREAS, the Company has previously granted the Executive the LTIP Units (as defined in that form of Long Term Incentive Plan
Unit Agreement (the “Award Agreement”) under the BioMed Realty Trust, Inc. and BioMed Realty L.P. 2004 Incentive Award Plan (the
“Plan”)) set forth on Schedule A hereto (the “LTIP Units”) pursuant to the Plan, the Fourth Amended and Restated Agreement of Limited Partnership of BioMed Realty, L.P., as amended from time to
time (the “Partnership Agreement”), and an Award Agreement between the Company and the Executive (the “LTIP Unit Award Agreement”); and 

WHEREAS, the Company and the Executive mutually desire to cancel and terminate the LTIP Units and terminate any rights and interests the
Executive may have in or to the LTIP Units, the LTIP Unit Award Agreement, the Partnership Agreement and the Plan (as they relate to the LTIP Units). 

NOW, THEREFORE, in consideration of the covenants and undertakings contained herein, and for other good and valuable consideration, the
sufficiency of which is hereby acknowledged, the Company and the Executive hereby agree as follows: 
 1. Cancellation. Effective as
of the date of this Agreement, the LTIP Units shall be cancelled and terminated, and all of the Executive’s rights and interests in or to the LTIP Units and under the LTIP Unit Award Agreement, the Partnership Agreement and the Plan (as they
relate to the LTIP Units) shall be cancelled and terminated and deemed null and void and of no force or effect. Effective as of the date of this Agreement, the LTIP Unit Award Agreement shall terminate and be of no further force or effect, and
neither the Company nor the Executive shall have any further rights or obligations thereunder. 
 2. Waiver. Effective as of the
date of this Agreement, the Executive hereby waives, relinquishes and gives up any and all right, title and interest in or to the LTIP Units, the LTIP Unit Award Agreement, the Partnership Agreement and the Plan (as they relate to the LTIP Units).

 3. Consideration. In consideration of the foregoing, the Company shall pay (or shall
cause its payroll agent to pay) to the Executive a single lump-sum cash payment in an aggregate amount equal to $1,068,750.00 (the “LTIP Unit Consideration”), subject to reduction for any applicable payroll and withholding
taxes, which shall constitute full and complete payment in settlement of the LTIP Units. Such payment shall be made to the Executive not later than December 31, 2015. 

4. Termination of the Merger Agreement. In the event that the Merger Agreement is terminated pursuant to its terms, the Executive
agrees to repay the LTIP Unit Consideration to the Company within thirty (30) days following such termination of the Merger Agreement. 

5. Further Actions. The Executive agrees to take any and all actions, and to execute and deliver any and all documents, that may be
requested by the Company in order to accomplish the transactions contemplated by this Agreement or to effectuate the intent hereof. 
 6.
Tax Consequences. The Company is making no warranties or representations to the Executive with respect to the tax consequences of the transactions contemplated by this Agreement. The Executive is hereby advised to consult with the
Executive’s own personal legal, accounting, tax and/or financial professional advisors with respect to the tax consequences associated with transactions contemplated by this Agreement. 

7. Governing Law. This Agreement shall be administered, interpreted and enforced under the laws of the State of Maryland without
regard to the conflicts of law principles thereof. 
 8. Severability. The invalidity or unenforceability of any provision of this
Agreement shall not affect the validity or enforceability of any other provision of this Agreement. 
 9. Entire Agreement. This
Agreement and Schedule A hereto constitute the entire and complete agreement between the Company and the Executive with respect to the subject matter hereof and supersedes any and all other agreements or arrangements, whether oral or written,
between the Company and the Executive (or any predecessor or representative thereof) with respect to the subject matter hereof. 
 10.
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original and all of which together shall constitute one and the same instrument. 

[Signature Page Follows] 

 IN WITNESS WHEREOF, the Company and the Executive have caused this Agreement to be executed as
of the date first above written. 
  

			
	BIOMED REALTY TRUST, INC.,
	a Maryland corporation
		
	By: 	 	 /s/ Karen A. Sztraicher

	Name:	 	Karen A. Sztraicher
	Title:	 	Executive Vice President, Asset Management
	
	 BIOMED REALTY, L.P.,
 a
Maryland limited partnership

		
	By:	 	 /s/ Karen A. Sztraicher

	Name:	 	Karen A. Sztraicher
	Title:	 	Executive Vice President, Asset Management
	
	EXECUTIVE
	
	 /s/ Gary A. Kreitzer

	Gary A. Kreitzer

 Schedule A 

 

			
	 Grant Date
	  	 Number of LTIP Units

	January 31, 2007	  	45,000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]